Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping.

Blood - 15 Dec 2008

Johnson David C, Corthals Sophie, Ramos Christine, Hoering Antje, Cocks Kim, Dickens Nicholas J, Haessler Jeff, Goldschmidt Harmut, Child J Anthony, Bell Sue E, Jackson Graham, Baris Dalsu, Rajkumar S Vincent, Davies Faith E, Durie Brian G M, Crowley John, Sonneveld Pieter, Van Ness Brian, Morgan Gareth J

Abstract excerpt

A venous thromboembolism (VTE) with the subsequent risk of pulmonary embolism is a major concern in the treatment of patients with multiple myeloma with thalidomide. The susceptibility to developing a VTE in response to thalidomide therapy is likely to be influenced by both genetic and environmental factors. To test genetic variation associated with treatment related VTE in patient peripheral blood DNA, we used a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Data Collection

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hemostasis

Share to Multiple Myeloma

Share to Pharmaceutical Preparations

Share to Pharmacogenetics

Share to Thalidomide

Share to Venous Thrombosis

Source

Open in PubMed Open full text

Identifiers

PMID: 18805967
DOI: 10.1182/blood-2008-02-140434
PMCID: PMC3601865

Genes

MIP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping.PMID 18805967Read ↗

Association study of selected genetic polymorphisms and occurrence of venous thromboembolism in patients with multiple myeloma who were treated with thalidomide.Semantic proximity Read ↗

Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma.Semantic proximity Read ↗

Genomic Profiling Identifies Somatic Mutations Predicting Thromboembolic Risk in Patients with Solid TumorsSemantic proximity Read ↗

Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors.Semantic proximity Read ↗

Genetic variations in multiple myeloma II: association with effect of treatment.Semantic proximity Read ↗

Association between tumour somatic mutations and venous thromboembolism in the 100,000 Genomes Project cancer cohort: a study protocolSemantic proximity Read ↗

Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide-based regimens.Semantic proximity Read ↗

Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinations.Semantic proximity Read ↗

A review of the venous thrombotic issues associated with multiple myeloma.Semantic proximity Read ↗

VEGF, VEGFR2 and GSTM1 polymorphisms in outcome of multiple myeloma patients treated with thalidomide-based regimens.Semantic proximity Read ↗

[The genetics of thrombosis in cancer].Semantic proximity Read ↗

Associations of tumor somatic mutations with cancer-associated venous thromboembolism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.